MedTrace Logo

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

NCT04092907 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-08-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy and safety of HBM9036 Ophthalmic Solution versus placebo in the treatment of dry eye

Conditions

  • Dry Eye

Interventions

DRUG

HBM9036 0.25% Ophthalmic Solution

Ophthalmic Solution

DRUG

placebo

Ophthalmic Solution

Sponsors & Collaborators

  • Harbour BioMed (Guangzhou) Co. Ltd.

    lead INDUSTRY

Principal Investigators

  • Lixin XIE, Academician · QINGDAO EYE HOSPITAL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-22
Primary Completion
2019-07-03
Completion
2019-07-10

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04092907 on ClinicalTrials.gov